Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GNC partners with China-based Bright Food

This article was originally published in The Tan Sheet

Executive Summary

General Nutrition Centers plans to enter the Chinese market in mid 2010 after it finalizes a joint venture with Bright Food's subsidiary Shanghai Yangtang Group, the Pittsburgh-based nutritional product retailer announces Feb. 12. The firms entered a memorandum of understanding and expect to launch products mid-year in China's large to medium-sized cities under the name GNC China. They also may consider retailing, distribution and production opportunities, according to the release. Euromonitor International estimates China's OTC vitamin and supplement segment sold $8 billion based on retail value in 2009, and notes the segment is growing at a rate of 4 percent in local currency (1"The Tan Sheet" Feb. 1, 2010)

You may also be interested in...



Sanofi Expands Consumer Health Reach With Minsheng VMS Joint Venture

A joint venture with Minsheng Pharmaceutical Group brings Sanofi-Aventis one step closer to its goal of doubling its consumer health care business in five years and opens a powerful distribution channel in China through which the French firm can market newly acquired supplements

Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch

The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.

Sandoz Pledges Price Stability Amid Coronavirus

Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.

Topics

UsernamePublicRestriction

Register

PS103817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel